共 68 条
[1]
DeSantis CE(2014)Cancer treatment and survivorship statistics, 2014 CA Cancer J Clin. 64 252-271
[2]
Lin CC(2014)EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013 Eur Urol. 65 124-137
[3]
Mariotto AB(2012)Radical prostatectomy versus observation for localized prostate cancer N Engl J Med. 367 203-213
[4]
Heidenreich A(2014)Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer Eur Radiol. 24 3161-3170
[5]
Bastian PJ(2015)The role of MRI in active surveillance for prostate cancer Curr Urol Rep. 16 507-92
[6]
Bellmunt J(2013)ACR appropriateness criteria prostate cancer–pretreatment detection, staging, and surveillance J Am Coll Radiol. 10 83-139
[7]
Wilt TJ(2004)Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension Radiology. 232 133-3711
[8]
Brawer MK(2014)Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score Clin Cancer Res. 20 3705-S24
[9]
Jones KM(2008)Evaluating localized prostate cancer and identifying candidates for focal therapy Urology. 72 S12-1738
[10]
Gondo T(2012)Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer J Urol. 188 1732-977